Mills Kenneth T. 4
4 · REGENXBIO Inc. · Filed Mar 31, 2025
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Mills Kenneth T.
Director
Transactions
- Exercise/Conversion
Common Stock
2025-03-27$3.76/sh+30,752$115,628→ 475,103 total - Exercise/Conversion
Stock Options (Right to Buy)
2025-03-27−30,752→ 20,602 totalExercise: $3.76Exp: 2025-05-19→ Common Stock (30,752 underlying)
Footnotes (1)
- [F1]The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter.